Literature DB >> 17881554

Streptococcus agalactiae serotype Ib as an agent of meningitis in two adult nonpregnant women.

E R Martins1, C Florindo, F Martins, I Aldir, M J Borrego, L Brum, M Ramirez, J Melo-Cristino.   

Abstract

Two temporally and geographically clustered cases of meningitis caused by Streptococcus agalactiae expressing the infrequent Ib serotype are reported. Characterization by pulsed-field gel electrophoresis and multilocus sequence typing revealed that the isolates were identical and represented the widely distributed ST10/ST8 lineage associated with serotype Ib.

Entities:  

Mesh：

Year:  2007        PMID： 17881554      PMCID： PMC2168519          DOI： 10.1128/JCM.01358-07

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  11 in total

1.  Fatal group B streptococcal meningitis in a previously healthy young adult.

Authors:  A J Barile; A J Kallen; M R Wallace
Journal:  Clin Infect Dis       Date:  1999-01       Impact factor: 9.079

2.  Group B streptococcal meningitis in a patient with horizontal transmission: beware of toothbrushing on Sunday mornings.

Authors:  Amélie Guihot; François Bricaire; Philippe Bossi
Journal:  J Infect       Date:  2005-04       Impact factor: 6.072

3.  Multilocus sequence typing of Swedish invasive group B streptococcus isolates indicates a neonatally associated genetic lineage and capsule switching.

Authors:  Shi-Lu Luan; Margareta Granlund; Mats Sellin; Teresa Lagergård; Brian G Spratt; Mari Norgren
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

4.  Group B streptococcal disease in nonpregnant adults.

Authors:  M M Farley
Journal:  Clin Infect Dis       Date:  2001-07-20       Impact factor: 9.079

Review 5.  Group B streptococcal meningitis in adults: report of twelve cases and review.

Authors:  P Domingo; N Barquet; M Alvarez; P Coll; J Nava; J Garau
Journal:  Clin Infect Dis       Date:  1997-11       Impact factor: 9.079

6.  Serotype identification of group B streptococci by PCR and sequencing.

Authors:  Fanrong Kong; Sonia Gowan; Diana Martin; Gregory James; Gwendolyn L Gilbert
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

7.  Streptococcus agalactiae in a large Portuguese teaching hospital: antimicrobial susceptibility, serotype distribution, and clonal analysis of macrolide-resistant isolates.

Authors:  J Figueira-Coelho; M Ramirez; M J Salgado; J Melo-Cristino
Journal:  Microb Drug Resist       Date:  2004       Impact factor: 3.431

8.  Analysis of group B streptococcal isolates from infants and pregnant women in Portugal revealing two lineages with enhanced invasiveness.

Authors:  E R Martins; M A Pessanha; M Ramirez; J Melo-Cristino
Journal:  J Clin Microbiol       Date:  2007-08-15       Impact factor: 5.948

9.  Multilocus sequence typing system for group B streptococcus.

Authors:  Nicola Jones; John F Bohnsack; Shinji Takahashi; Karen A Oliver; Man-Suen Chan; Frank Kunst; Philippe Glaser; Christophe Rusniok; Derrick W M Crook; Rosalind M Harding; Naiel Bisharat; Brian G Spratt
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

10.  A population-based assessment of invasive disease due to group B Streptococcus in nonpregnant adults.

Authors:  M M Farley; R C Harvey; T Stull; J D Smith; A Schuchat; J D Wenger; D S Stephens
Journal:  N Engl J Med       Date:  1993-06-24       Impact factor: 91.245
View more
  9 in total

1.  Clinical strains of Streptococcus agalactiae carry two different variants of pathogenicity island XII.

Authors:  Eugenia Kuleshevich; Joseph Ferretti; Ilda Santos Sanches; Natesan Balasubramanian; Barbara Spellerberg; Androulla Efstratiou; Paula Kriz; Kornelia Grabovskaya; Olga Arjanova; Alevtina Savitcheva; Valentin Shevchenko; Anton Rysev; Alexander Suvorov
Journal:  Folia Microbiol (Praha)       Date:  2017-03-18       Impact factor: 2.099

2.  Group B streptococcal disease in nonpregnant patients: emergence of highly resistant strains of serotype Ib in Taiwan in 2006 to 2008.

Authors:  Ying-Hsiang Wang; Lin-Hui Su; Jiun-Nun Hou; Tsung-Han Yang; Tzou-Yien Lin; Chishih Chu; Cheng-Hsun Chiu
Journal:  J Clin Microbiol       Date:  2010-05-05       Impact factor: 5.948

3.  Dominance of serotype Ia among group B Streptococci causing invasive infections in nonpregnant adults in Portugal.

Authors:  E R Martins; J Melo-Cristino; M Ramirez
Journal:  J Clin Microbiol       Date:  2012-01-04       Impact factor: 5.948

4.  Evidence for rare capsular switching in Streptococcus agalactiae.

Authors:  Elisabete Raquel Martins; José Melo-Cristino; Mário Ramirez
Journal:  J Bacteriol       Date:  2009-12-18       Impact factor: 3.490

5.  Molecular characterization of human-colonizing Streptococcus agalactiae strains isolated from throat, skin, anal margin, and genital body sites.

Authors:  Nathalie van der Mee-Marquet; Laure Fourny; Laurence Arnault; Anne-Sophie Domelier; Mazen Salloum; Marie-Frédérique Lartigue; Roland Quentin
Journal:  J Clin Microbiol       Date:  2008-07-16       Impact factor: 5.948

6.  Distribution of pilus islands in Streptococcus agalactiae that cause human infections: insights into evolution and implication for vaccine development.

Authors:  E R Martins; A Andreu; J Melo-Cristino; M Ramirez
Journal:  Clin Vaccine Immunol       Date:  2012-12-26

7.  Streptococcus agalactiae Meningitis in Adult Patient: A Case Report and Literature Review.

Authors:  Fahmi Yousef Khan
Journal:  Case Rep Infect Dis       Date:  2016-01-21

8.  Streptococcus agalactiae septicemia in a patient with diabetes and hepatic cirrhosis.

Authors:  Renan Pedroso Batista; Cristiane Rúbia Ferreira
Journal:  Autops Case Rep       Date:  2015-12-30

9.  Characterization of a new CAMP factor carried by an integrative and conjugative element in Streptococcus agalactiae and spreading in Streptococci.

Authors:  Sarah Chuzeville; Aurore Puymège; Jean-Yves Madec; Marisa Haenni; Sophie Payot
Journal:  PLoS One       Date:  2012-11-09       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.